These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8435336)

  • 1. Factors influencing haematological recovery in 53 patients with acute myeloid leukaemia in first remission after autologous bone marrow transplantation.
    Pendry K; Alcorn MJ; Burnett AK
    Br J Haematol; 1993 Jan; 83(1):45-52. PubMed ID: 8435336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission.
    Petersen FB; Lynch MH; Clift RA; Appelbaum FR; Sanders JE; Bensinger WI; Benyunes MC; Doney K; Fefer A; Martin P
    J Clin Oncol; 1993 Jul; 11(7):1353-60. PubMed ID: 8315433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation for patients with acute myeloid leukaemia: prospective follow-up study.
    Mak YK; Chan CH; Chu YC; Chen YT; Lau CK; Lau JS
    Hong Kong Med J; 2000 Mar; 6(1):37-42. PubMed ID: 10793401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.
    Smith BD; Jones RJ; Lee SM; Piantadosi S; Vala MS; Fuller D; Gore SD; Noga SJ; O'Donnell PV; Braine H; Vogelsang GB; Fuchs EJ; Flinn IW; Brodsky RA; Ambinder RF; Miller CB
    Br J Haematol; 2002 Jun; 117(4):907-13. PubMed ID: 12060130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy with autologous marrow rescue for malignant brain tumors: analysis of the impact of prior chemotherapy and cranio-spinal irradiation on hematopoietic recovery.
    Faulkner LB; Lindsley KL; Kher U; Heller G; Black P; Finlay JL
    Bone Marrow Transplant; 1996 Mar; 17(3):389-94. PubMed ID: 8704692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic reconstitution after high-dose chemotherapy and autologous nonfrozen bone marrow rescue.
    Köppler H; Pflüger KH; Havemann K
    Ann Hematol; 1991 Nov; 63(5):253-8. PubMed ID: 1958749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience.
    Chopra R; Goldstone AH; McMillan AK; Powles R; Smith AG; Prentice HG; Reid C; Marcus R; Bell A; Milligan D
    J Clin Oncol; 1991 Oct; 9(10):1840-7. PubMed ID: 1919634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow transplantation for patients with acute myeloid leukaemia and acute lymphoblastic leukaemia--a comparison.
    Anderson CC; Goldstone AH; Linch DC; Jones HM; Franklin IM; Boughton BJ; Cawley JC; Richards JD
    Bone Marrow Transplant; 1987 Feb; 1(3):271-9. PubMed ID: 3332138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors which affect the CFU-GM content of the peripheral blood haemopoietic progenitor cell harvests in patients with acute myeloid leukaemia.
    Jowitt SN; Chang J; Morgenstern GR; Howe T; Ryder WD; Testa NG; Scarffe JH
    Br J Haematol; 1998 Mar; 100(4):688-94. PubMed ID: 9531335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for autologous bone marrow transplantation in acute leukaemia: a single centre study of 105 patients.
    Cordonnier JM; Mercier M; Plouvier E; Hervé P; Cahn JY
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):293-300. PubMed ID: 7971248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.
    Yeager AM; Kaizer H; Santos GW; Saral R; Colvin OM; Stuart RK; Braine HG; Burke PJ; Ambinder RF; Burns WH
    N Engl J Med; 1986 Jul; 315(3):141-7. PubMed ID: 3523241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.
    Chantry AD; Snowden JA; Craddock C; Peggs K; Roddie C; Craig JI; Orchard K; Towlson KE; Pearce RM; Marks DI;
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1310-7. PubMed ID: 17162213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Older patients with high-risk fungal infections can be successfully allografted using non-myeloablative conditioning in combination with intensified supportive care regimens.
    Hermann S; Klein SA; Jacobi V; Thalhammer A; Bialleck H; Duchscherer M; Wassmann B; Hoelzer D; Martin H
    Br J Haematol; 2001 May; 113(2):446-54. PubMed ID: 11380415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Jerjis S; Roovers E; Muus P; Schaap N; de Witte T
    Bone Marrow Transplant; 1998 Jul; 22(1):13-9. PubMed ID: 9678790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
    Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
    Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up.
    Vaidya SJ; Atra A; Bahl S; Pinkerton CR; Calvagna V; Horton C; Milan S; Shepherd V; Brain C; Treleaven J; Powles R; Tait D; Meller ST
    Bone Marrow Transplant; 2000 Mar; 25(6):599-603. PubMed ID: 10734293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.